PDF herunterladen
Thromb Haemost 1993; 70(05): 881
DOI: 10.1055/s-0038-1649692
Letter to the Editor
Schattauer GmbH Stuttgart

Rebuttal to the Letter to the Editor by Dr. Scharrer et al.

I Wieczorek
Department of Haematology, Royal Infirmary of Edinburgh, Lauriston Place, Edinburgh EH3 9YW, UK
,
C A Ludlam
Department of Haematology, Royal Infirmary of Edinburgh, Lauriston Place, Edinburgh EH3 9YW, UK
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 08. April 1993

Accepted after revision 05. Juli 1993

Publikationsdatum:
05. Juli 2018 (online)

Auch verfügbar auf
  als PDF herunterladen  Lizenzen und Reprints
 

  • References

  • 1 Keber D. On the use of different correction factors for haemoconcentration. Thromb Haemostas 1983; 49: 245
    PubMedGoogle Scholar
  • 2 Robertson B, Pandolfi M, Nilsson IM. Response of local fibrinolytic activity to venous occlusion of arms and legs. Acta Chir Scand 1972; 138: 437-440
    PubMedGoogle Scholar
  • 3 Chan TK, Chan V. The effect of venous occlusion on antithrombin III plasminogen activator and fibrinogen degradation product (fragment E). Thromb Res 1979; 15: 525-534
    PubMedGoogle Scholar
  • 4 Grignani G, Gamba G, Geroldi D, Pacchiarini L, Solerte B, Ferrari E, Ascari E. Enhanced antithrombotic mechanisms in patients with maturity onset diabetes without thromboembolic complications. Thromb Haemostas 1981; 46: 648-651
    PubMedGoogle Scholar
  • 5 Wieczorek I, MacGregor IR, Prescott RJ, Ludlam CA. The fibrinolytic system and proteins C and S in treated polycythaemia rubra vera. Blood Coag Fibrinol 1992; 3: 823-826
    CrossrefPubMedGoogle Scholar